Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against First High-School Education Grou…


Robbins Geller Rudman & Dowd LLP announces that purchasers of First High-School Education Group Co., Ltd. (NYSE: FHS) American Depositary Shares (“ADSs”) in or traceable to First High-School Education’s March 2021 initial public offering (“IPO”) have until Monday, July 11, 2021 to seek appointment in Dagan Investments LLC v. First High-School Education Group Co., Ltd., No. 22-cv-03831 (S.D.N.Y.). Filed by Robbins Geller, the First High-School Education class action lawsuit charges First High-School Education, certain of its top executives and directors, the IPO’s underwriters, as well as others with violations of the Securities Act of 1933.

If you suffered substantial losses and wish to serve as lead plaintiff, please provide your information here:

https://www.rgrdlaw.com/cases-first-high-school-education-group-co-ltd-class-action-fhs.html

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: First High-School Education provides tutoring services and operates private high schools in Western China. In the week immediately prior to the IPO – from March 4, 2021 through March 11, 2021 – China held its annual “Two Sessions” parliamentary meetings, where the two main political bodies of China meet, discuss, and reveal plans for China’s policies involving the economy, military, trade, diplomacy, education, the environment, and other issues. Unbeknownst to investors until after the IPO, Chinese government leaders in attendance at the Two Sessions meetings had proposed – and ultimately adopted – stringent regulations governing the educational industry with material adverse repercussions for First High-School Education’s business, operations, and financial prospects.

Specifically, the First High-School Education class action lawsuit alleges that the IPO’s Registration Statement made inaccurate statements of material fact because defendants failed to disclose the following adverse…



Source link